Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP105155.RAYi0pBuiez5wiGyhW87YLKMoPI9rX_bce-gk6bBFPriM130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105155.RAYi0pBuiez5wiGyhW87YLKMoPI9rX_bce-gk6bBFPriM130_provenance.
• NP105156.RAivcOfhPqm46QZVb9p77P32NlM2pjWXW6DgnaAUt7cEU130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105156.RAivcOfhPqm46QZVb9p77P32NlM2pjWXW6DgnaAUt7cEU130_provenance.
• NP105157.RAuNSJbb01v81mtk5445GNkeiVaEpMgttke-Le99DQsf4130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105157.RAuNSJbb01v81mtk5445GNkeiVaEpMgttke-Le99DQsf4130_provenance.
• NP105161.RApRoJurzP-4EwJyIr0h3tRlJH2uMEIo7yf6UtI925EZY130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105161.RApRoJurzP-4EwJyIr0h3tRlJH2uMEIo7yf6UtI925EZY130_provenance.
• NP105162.RAGmpxcIjImnco3EJR85K-J4TAm-4f6w2YUxIBDLtbkag130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105162.RAGmpxcIjImnco3EJR85K-J4TAm-4f6w2YUxIBDLtbkag130_provenance.
• NP105159.RAyhb-mtK12T-RrpKSGgGzHBB9KfBVTHULlcP2-iiyZic130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105159.RAyhb-mtK12T-RrpKSGgGzHBB9KfBVTHULlcP2-iiyZic130_provenance.
• NP105160.RA6REXCaw3i_gqDzYXKmCfjUkalrDc9w2tkWrjiVUlaxk130_assertion description "[Heterozygote carriers of SNPs in CYP1A2 1545T>C, -164C>A and -740T>G; CYP2A6 -47A>C; MDR1 3435T>C; NAT1 1088T>A and 1095A>C; GSTA2 S112T; GSTM3 V224I and MTHFR A222V had altered risk of developing lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105160.RA6REXCaw3i_gqDzYXKmCfjUkalrDc9w2tkWrjiVUlaxk130_provenance.